4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Progression-free survival, overall survival and immunophenotyping outcomes for patients with stage III-IV head and neck cancer and cisplatin contraindication treated with definitive radiotherapy plus pembrolizumab

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          International Journal of Radiation Oncology*Biology*Physics
          International Journal of Radiation Oncology*Biology*Physics
          Elsevier BV
          03603016
          April 2020
          April 2020
          : 106
          : 5
          : 1221
          Article
          10.1016/j.ijrobp.2020.02.003
          156124b7-08a0-4ba5-b166-d7d98f420dc0
          © 2020

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article